Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
DFDV Resumes SOL Purchases, Expands Treasury to 2.33M SOL and SOL Equivalents
-
Change Agents Announces 1-for-20 Reverse Stock Split
-
Sportradar and Polymarket Significantly Expand Prediction Market Partnership to More Than 20 Global Sports Leagues and Competitions
-
CTW to Participate and Present at Upcoming September Investment Conferences
-
Safe Harbor Institutional to Highlight Scalable Cannabis Banking Infrastructure at PBC Conference
-
Mental Health America announces Dr. Tia Dole as new president and CEO
-
ICU Medical to Participate in Upcoming Investor Conferences
-
Orchestra BioMed to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
-
Edible Garden Awarded New Target Fresh Herb Program for Peak Holiday Season
-
Luessen Announces Listing on Indoex, Bringing Renewable Energy Onchain
-
Biomerica Announces $2.23 Million Financing
-
Debt Settlement Enrollment Linked to Greater Credit Score Declines Than Bankruptcy, New TransUnion Research Finds
-
Bond Signs Definitive Citywide Agreement to Protect 10,000 Jerusalem Municipal Workers
-
Callan Power to Acquire Williston Basin Non-Operated Oil and Gas Assets with $48 Million Proved PV-10 and $83 Million 3P PV-10 from The Pfanenstiel Company, Significantly Expanding Energy Assets
-
ZenaTech Named 2026 “Drone Technology of the Year” Winner by AgTech Breakthrough Awards for Its ZenaDrone Precision Agriculture Solutions
-
Form 8.3 Picton Property Income Limited
-
Form 8.3 LondonMetric Property Plc & Schroder Real Estate Investment Trust Limited
-
BranchOut Food Inc. Announces $2.79 Million Underwritten Public Offering
-
ServiceUp and Stellantis Pro One Partner to Transform the Fleet Repair Experience
-
AZIO AI Increases Estimated Sales Pipeline to Approximately $307 Million for Up to 512 NVIDIA HGX B300 Systems in Expanded Power Champion Agreement
-
Harmony Biosciences to Participate in 2026 Cantor Global Healthcare Conference
-
Conavi Medical Reports Fiscal Third Quarter 2026 Results and Operational Highlights
-
EcoEngineers Approved as Auditor Under the Ammonia Energy Association's Ammonia Certification System
-
EcoEngineers Approved as Auditor Under the Ammonia Energy Association's Ammonia Certification System
-
Learning Tree Launches Instructor-Led Preparation Courses for Anthropic’s Claude Certifications
-
BranchOut Secures Approximately $750,000 in Initial Orders for New Front-of-Club Multipack Product Line and Dried Cheesecake Bites with Nation's Largest Warehouse Club Retailer
-
Form 8.3 - Gooch & Housego plc - Octopus Investments
-
Eascra Biotech Appoints Chief Scientific Officer to Lead Commercialization Push
-
20+ New Local AEO Insights Highlighted as Part of “Cairrot 2.0” Preview at spARK Labs by ARK Invest
-
Synack to Present on AI Pentesting and Human Validation at BrightTALK Summit
-
HPQ and Novacium Deliver Custom-Configured Battery Packs to Three European Drone Manufacturers for Final-Stage Evaluation
-
Monarch Private Capital Marks Major Milestone With Substantial Completion of Sunraycer's Midpoint and Gaia Solar Projects in Texas
-
Noah Medical Announces Collaboration to Advance Imaging in Robotic-Assisted Bronchoscopy
-
HealthEquity Reports Second Quarter Ended July 31, 2026 Financial Results
-
Freshpet, Inc. to Participate in the Barclays 19th Annual Global Consumer Conference
-
Eascra Biotech Awarded $7.96 Million NASA InSPA Phase 2 Contract to Advance Space-Manufactured Nanomedicine
-
CytomX Therapeutics Announces FDA Fast Track Designation for Varsetatug masetecan (“Varseta-M”) for Relapsed/Refractory Metastatic Colorectal Cancer (R/R mCRC)
-
Airia Advances MCP Gateway With Intelligent Routing and Enterprise Access Controls
-
Rectify Pharmaceuticals Presents Discovery of Clinical Candidate RTY-406, a Novel Disease-Modifying Therapy for the Treatment of PSC at ACS Fall 2026 Meeting
-
Global Industry Leaders Presenting at 18th Annual Capital Link Shipping & Marine Services Forum - Tuesday, September 15, 2026, at 116 Pall Mall in London
-
Cardurion Pharmaceuticals Announces Late-Breaking Presentation of Phase 2 Results for Tovinontrine (CRD-750), a PDE9 Inhibitor, in Heart Failure
-
Ninepoint Partners Announces Ninepoint 2026 Short Duration Flow-Through Limited Partnership
-
Enviri Corporation to Participate in Upcoming Investor Conferences
-
GoldHaven Commences Maiden Drill Program at Magno Project, Targeting Historic Kuhn Tungsten Zone
-
PodcastOne (Nasdaq: PODC) Acquires Exclusive Sales and Distribution Rights to Dropping Names…and Other Things with Brent & Jonny in Multi-Year Deal
-
Artelo Biosciences Announces Reverse Stock Split
-
Milestone Pharmaceuticals Announces Data Presented at ESC Congress 2026 on the Impact of Paroxysmal Supraventricular Tachycardia (PSVT) on Patients’ Daily Lives and Quality of Life Between Episodes
-
MBX Biosciences Announces First Patient Dosed in Pivotal Phase 3 oPTimize Trial of Once-Weekly Canvuparatide in Adults with Hypoparathyroidism
-
For Gen Z the American Dream Has No Borders
-
Entera to Participate in Upcoming Fall Investor Conferences
